CD8A and COVID-19: Similarly, Mathew and colleagues (2020) observed that among patients with COVID-19, activation levels of CD8 and CD4 T cells (via HLA-DR and CD38 co-expression) were similar to the antiviral responses that have been observed for other infections [21].